Overview

Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial

Status:
Not yet recruiting
Trial end date:
2020-10-30
Target enrollment:
Participant gender:
Summary
The use of both levamisole & Isoprinosine has both synergistic and complementary effect in the treatment of COVID 19 infection
Phase:
Phase 3
Details
Lead Sponsor:
Cairo University
Treatments:
Azithromycin
Hydroxychloroquine
Inosine Pranobex
Levamisole